ITeos Therapeutics Other Current Liabilities

ITeos Therapeutics (ITOS) currently reports a other current liabilities of $61M as of June 2025. That compares with $21M in the prior-year period — up 194.4% year over year. Use the charts on this page to explore ITeos Therapeutics's other current liabilities history and peer comparisons.

ITeos Therapeutics's other current liabilities increased from $21M to $61M — a 194.4% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

ITeos Therapeutics reported $61M in other current liabilities as of June 2025. That compares with $21M in the prior-year period — up 194.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $61M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for ITeos Therapeutics, and consider following ITOS for alerts when major investors trade the stock.

ITeos Therapeutics is classified in the Healthcare sector. On other current liabilities, it currently shows $61M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ITOS with unrelated industries.